6-chloro-3-methyl-7-nitro-2,3,4,5-tetrahydro-1H-3-benzazepine | 73943-11-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯氮卓类
• 英文名称: 6-chloro-3-methyl-7-nitro-2,3,4,5-tetrahydro-1H-3-benzazepine
• 英文别名: 6-chloro-3-methyl-7-nitro-2,3,4,5-tetrahydro-1H-benzo[d]azepine；6-chloro-3-methyl-7-nitro-1,2,4,5-tetrahydro-3-benzazepine
• CAS: 73943-11-0
• 化学式: C₁₁H₁₃ClN₂O₂
• 分子量: 240.689
• InChiKey: ROKNURNBPSXKMO-UHFFFAOYSA-N

物化性质

• 沸点：
  361.3±42.0 °C(Predicted)
• 密度：
  1.274±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  16
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  49.1
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  6-chloro-3-methyl-7-nitro-2,3,4,5-tetrahydro-1H-3-benzazepine 在 1-氯乙基氯甲酸酯 作用下， 以 1,2-二氯乙烷 为溶剂， 反应 5.0h， 以53%的产率得到6-chloro-7-nitro-2,3,4,5-tetrahydro-1H-benzo[d]azepine
  参考文献：
  名称：

  Synthesis and structure–activity relationships of a series of benzazepine derivatives as 5-HT2C receptor agonists

  摘要：

  To identify potent and selective 5-HT2C receptor agonists, a series of novel benzazepine derivatives were synthesized, and their structure-activity relationships examined. The compounds were evaluated for their 5-HT2C, 5-HT2A, and 5-HT2B receptor binding affinity and intrinsic activity for the 5-HT2C and 5-HT2A receptors. Among these compounds, 6,7-dichloro-2,3,4,5-tetrahydro-1H-3-benzazepine (6) was effective in a rat penile erection model when administered po, which is a symptom of the serotonin syndrome reflecting 5-HT2C receptor activation. Moreover, compound 6 was characterized as a partial agonist of 5-HT2A receptors; therefore, it had little effect on the cardiovascular system. (C) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2007.12.009
• 作为产物：
  描述：

  9-氯-3-甲基-1,2,4,5-四氢-3-苯并氮杂卓 在 硫酸 、 硝酸 作用下， 反应 1.0h， 以47%的产率得到6-chloro-3-methyl-7-nitro-2,3,4,5-tetrahydro-1H-3-benzazepine
  参考文献：
  名称：

  Synthesis and structure–activity relationships of a series of benzazepine derivatives as 5-HT2C receptor agonists

  摘要：

  To identify potent and selective 5-HT2C receptor agonists, a series of novel benzazepine derivatives were synthesized, and their structure-activity relationships examined. The compounds were evaluated for their 5-HT2C, 5-HT2A, and 5-HT2B receptor binding affinity and intrinsic activity for the 5-HT2C and 5-HT2A receptors. Among these compounds, 6,7-dichloro-2,3,4,5-tetrahydro-1H-3-benzazepine (6) was effective in a rat penile erection model when administered po, which is a symptom of the serotonin syndrome reflecting 5-HT2C receptor activation. Moreover, compound 6 was characterized as a partial agonist of 5-HT2A receptors; therefore, it had little effect on the cardiovascular system. (C) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2007.12.009

文献信息

• 6-Phenyl thio- and 6-cyclohexyl thio-2,3,4,5-tetrahydro-1H-3-benzazepines
  申请人：SmithKline Corporation

  公开号：US04265890A1

  公开（公告）日：1981-05-05

  Mercapto substituted-2,3,4,5-tetrahydro-1H-3-benzazepines having dopamine receptor blocking activity are prepared from o-quinones or via standard preparative procedures.

  巯基取代的-2,3,4,5-四氢-1H-3-苯并哌啶具有多巴胺受体阻断活性，可通过邻醌或标准制备程序制备。
• Development of an affinity ligand for purification of .alpha.2-adrenoceptors from human platelet membranes
  作者：R. M. DeMarinis、A. J. Krog、D. H. Shah、J. Lafferty、K. G. Holden、J. P. Hieble、W. D. Matthews、J. W. Regan、R. J. Lefkowitz、M. G. Caron

  DOI：10.1021/jm00373a018

  日期：1984.7

  prepared as affinity ligands for this purpose. The best of these is 9-(allyloxy)-6-chloro-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SK&F 101253). This compound is an alpha 2-adrenoceptor antagonist, which was obtained by synthetic modification of 6-chloro-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SK&F 86466), a novel antagonist with high affinity for the alpha 2-receptor.

  人血小板含有与腺苷酸环化酶负偶联的α2-肾上腺素能受体。为了更好地了解这种α受体亚型与这种关键酶的相互作用，我们启动了一个程序来分离和表征α2-肾上腺素能受体。该报告描述了为此目的制备为亲和配体的一系列分子的合成和生物学特性。其中最好的是9-（烯丙氧基）-6-氯-3-甲基-2,3,4,5-四氢-1H-3-苯并ze庚因（SK＆F 101253）。该化合物是α2肾上腺素能受体拮抗剂，是通过对6-氯-3-甲基-2,3,4,5-四氢-1H-3-苯并ze庚因（SK＆F 86466）进行合成修饰而获得的，SK-F 86466对α2受体的亲和力。
• 6-Chloro-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its acid addition salts and its use as an intermediate
  申请人：SMITHKLINE BECKMAN CORPORATION

  公开号：EP0080012A1

  公开（公告）日：1983-06-01

  6-Chloro-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its acid addition salts and its use as an intermediate to prepare mercapto substituted-2,3,4,5-tetrahydro-1H-3- benzazepines as disclosed in European Patent Application No. 79102279.1.

  欧洲专利申请 79102279.1 号中公开的 6-氯-3-甲基-2,3,4,5-四氢-1H-3-苯并氮杂卓、其酸加成盐及其作为中间体制备巯基取代的-2,3,4,5-四氢-1H-3-苯并氮杂卓的用途。
• 2,3,4,5-Tetrahydro-1H-3-Benzazepines, process for their production and pharmaceutical compositions having dopamine receptor blocking activity
  申请人：SMITHKLINE BECKMAN CORPORATION

  公开号：EP0007070B1

  公开（公告）日：1983-01-19
• US4265890A
  申请人：——

  公开号：US4265890A

  公开（公告）日：1981-05-05